A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight

Clinical trial NCT06440980 · COMPLETED

Trial details

NCT number: NCT06440980
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Obese Overweight Obesity

Start date: 2024-06-24
Primary completion: 2025-06-02
Enrollment: 533

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.